- BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum
- IIROC Trade Resumption - BETR
- BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum
- IIROC Trading Halt - BETR
- BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board
- BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon
- BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19
- BetterLife Pharma Confirms Re-Pricing of Warrants
- BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group
- BetterLife Pharma Enters into a Licensing Agreement
BetterLife Pharma Inc (NPAT:MUN) closed at 0.12, 152.63% above the 52 week low of 0.0475 set on Apr 14, 2020.
0.0475Apr 14 20200.298Jul 10 2019
Markit short selling activity
|Market cap||29.26m CAD|
Data delayed at least 15 minutes, as of Jun 05 2020 07:00 BST.